A review of nutritional problems and the cystic fibrosis lung transplant patient

Pediatric Transplantation

Volumn 6, Issue 5, 2002, Pages 388-391

  Dosanjh, A ^a,b,c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Cystic fibrosis; Lung transplantation; Nutrition

Indexed keywords

ARTICLE; CYSTIC FIBROSIS; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; GASTROSTOMY; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; NUTRITIONAL DEFICIENCY; NUTRITIONAL REQUIREMENT; NUTRITIONAL SUPPORT; OSTEOPOROSIS; PATIENT CARE;

BODY MASS INDEX; CHILD; CYSTIC FIBROSIS; DIABETES COMPLICATIONS; HUMANS; LUNG TRANSPLANTATION; NUTRITION PHYSIOLOGY; NUTRITIONAL STATUS; OSTEOPOROSIS;

EID: 0036802755     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2002.00169.x     Document Type: Article

References (30)

1. Lynch JP, Martinez F. Lung transplantation: Who's a candidate? (Part 2). J Respir Dis 1996: 17: 393-412.
2. Bell SC, Bowerman AR, Davies CA, Campbell IA, Shale DJ, Elborn JS. Nutrition in adults with cystic fibrosis. Clin Nutr 1998: 17: 211-215.
3. Chaun H. Colonic disorders in adult cystic fibrosis. Can J Gastroenterol 2001: 15: 586-590.
4. Ott SM, Aitken ML. Osteoporosis in patients with cystic fibrosis. Clin Chest Med 1998: 19: 555-567.
5. Nomori H, Kobayashi R. Postoperative pulmonary complications in patients undergoing thoracic surgery with special reference to preoperative respiratory muscle strength and nutrition. J Jpn Assoc Thorac Surg 1994: 42: 1272-1275.
6. Sharples L, Hathaway T, Dennis C, et al. Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation. J Heart Lung Transplant 1993: 12: 669-674.
7. Shapiro BJ, Veeraraghavan S, Barbers RG. Lung transplantation for cystic fibrosis: An update and practical considerations for referring candidates. Curr Opin Pulm Med 1999: 5: 365-370.
8. Forli L, Pedersen JI, Bjortuft O, Vatn M, Boe J. Dietary support to underweight patients with end-stage pulmonary disease assessed for lung transplantation. Respiration 2001: 68: 51-57.
9. Pichard C, Kyle UG, Jolliet P, et al. Treatment of cachexia with recombinant growth hormone in a patient before lung transplantation: A case report. Crit Care Med 1999: 27: 1639-1642.
10. Forli L, Bjortuff O, Vatn M, Kofstad J, Boe J. A study of intensified dietary support in underweight candidates for lung transplantation. Ann Nutr Metab 2001: 45: 159-168.
11. Starnes VA, Lewiston N, Theodore J, et al. Cystic fibrosis. Target population for lung transplantation in North America in the 1990s. J Thorac Cardiovasc Surg 1992: 103: 1008-1014.
12. Ramsey BW, Farrell PM, Pencharz P, et al. Nutritional assessment and management in cystic fibrosis: A consensus report. Am J Clin Nutr 1992: 55: 108-116.
13. Madill J, Maurer JR, De Hoyos A. A comparison of preoperative and postoperative nutritional states of lung transplant recipients. Transplantation 1993: 56: 347-350.
14. Beck CE, Lin A, Robbins RC, Dosanjh A. Improvement in the nutritional and pulmonary profiles of cystic fibrosis patients undergoing bilateral sequential lung and heart-lung transplantation. Nutr Clin Practice 1997: 12: 216-221.
15. Schweibel C, Pin I, Barnoud D, et al. Prevalence and consequences of nutritional depletion in lung transplant candidates. Eur Respir J 2000: 16: 1050-1055.
16. Plochl W, Pezawaas L, Artemiou O, Grimm M, Klepetko W, Heismayr M. Nutritional status, ICU duration and ICU mortality in lung transplant recipients. Intensive Care Med 1996: 22: 1179-1185.
17. Madill J, Gutierrez C, Grossman J, et al. Nutritional assessment of the lung transplant patient: Body mass index as a predictor of a 90 day mortality following transplantation. J Heart Lung Transplant 2001: 20: 288-296.
18. Liou TG, Adler FR, Fitzsimmons SC, et al. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001: 153: 345-352.
19. Donovan DS, Papadopoulas A, Staron RB, et al. Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 1998: 157: 1892-1899.
20. Aris RM, Lester GE, Renner JB, et al. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Respir Crit Care Med 2000: 162 ((3 Part 1)): 941-946.
21. Haworth CS, Selby PL, Adams JE, Mawer EB, Horrocks AW, Webb AK. Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis. Thorax 2001: 56: 314-316.
22. Parasa RB, Maffulli N. Musculoskeletal involvement in cystic fibrosis. Bull Hosp Jt Dis 1999: 58: 37-44.
23. Schoch OD, Speich R, Schmid C, et al. Osteonecrosis after lung transplantation: Cystic fibrosis as a potential risk factor. Transplantation 2000: 69: 1629-1632.
24. Haworth C, Webb K, Egan J, et al. Bone histomorphometry in adult patients with cystic fibrosis. Chest 2000: 118: 434-439.
25. Haworth CS, Selby PL, Webb AK, Adams JE. Osteoporosis in adults with cystic fibrosis. J R Soc Med 1998: 91 (Suppl. 34): 14-18.
26. Yung B, Kemp M, Hooper J, Hodson ME. Diagnosis of cystic fibrosis related diabetes: A selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria. Thorax 1999: 54: 40-43.
27. Deieroi MH, Haug M. Review of select transplant subpopulations at high risk of failure from standard immunosuppressive therapy. Clin Transpl 2000: 14: 439-448.
28. Hoang K, Alpert S, Chen I, et al. Diabetes and dyslipidemia: New model for cardiac graft vascular disease in Lewis inbred rates (Abstract). J Heart Lung Transplant 1996: 15: S97.
29. Livi U, Caforio AL, Grassi G, et al. Mid-term results of heart transplantation in diabetic patients. J Cardiovasc Surg 1994: 35: 115-118.
30. Munoz E, Lonquist JL, Roadovancevic B, et al. Long-term results in diabetic patients undergoing heart transplantation in diabetic recipients. Surgery 1993: 114: 650-656.